Unilateral Galactocele In A Boy Who Received Risperidone : A Case Report Unilateral Galactocele In A Boy Who Received Risperidone
Article Sidebar
Main Article Content
Abstract
Galactocele, generally occurring in young women during or after lactation, is an extremely rare cause of breast mass in infants and children, particularly in males. Here, we report a 7-year and 5-month-old boy who had a painless mass at his left breast. The hormonal blood test revealed hyperprolactinemia, caused by minimum risperidone dosage. Our purpose was to emphasize the importance of including galactocele as a differential diagnosis in children receiving risperidone presented with breast mass. Furthermore, we would like to encourage establishing a standardized follow-up guideline for pediatric patients receiving this drug.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0)
The authors retain copyright and permit the journal the copyright of first publication
Articles, once having passed the review process and accepted for publication in the CDMH Journal, are copyrighted under the CDMH Journal, Department of Mental Health, Ministry of Public Health. Please be aware distribution of CDMH Journal content for commercial purposes without permission is expressly prohibited. However, distribution with intent to educate, advocate, or spread awareness within the general public and research communities is permitted and encouraged with the understanding that the CDMH Journal Editorial Board do not hold jurisdiction or liability for any accompanying comments, text, or information from third parties, either in favor for or against the original article’s assertions, conclusions, methodology, or content.
References
Ajmal, A., Joffe, H., & Nachtigall, L. B. (2014). Psychotropic-induced hyperprolactinemia: a clinical review. Psychosomatics, 55(1), 29-36. doi:10.1016/j.psym.2013.08.008
Aman, M. G., Binder, C., & Turgay, A. (2004). Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. J Child Adolesc Psychopharmacol, 14(2), 243-254. doi:10.1089/1044546041649020
Arabgol, F., Panaghi, L., & Nikzad, V. (2015). Risperidone Versus Methylphenidate in Treatment of Preschool Children With Attention-Deficit Hyperactivity Disorder. Iran J Pediatr, 25(1), e265. doi:10.5812/ijp.265
Biederman, J., Monuteaux, M. C., Mick, E., Spencer, T., Wilens, T. E., Silva, J. M., . . . Faraone, S. V. (2006). Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med, 36(2), 167-179. doi:10.1017/S0033291705006410
Boyle, M., Lakhoo, K., & Ramani, P. (1993). Galactocele in a male infant: case report and review of literature. Pediatr Pathol, 13(3), 305-308. doi:10.3109/15513819309048217
Brown, K. A., Samuel, S., & Patel, D. R. (2018). Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners. Transl Pediatr, 7(1), 36-47. doi:10.21037/tp.2017.08.02
Byerly, M., Suppes, T., Tran, Q. V., & Baker, R. A. (2007). Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives. J Clin Psychopharmacol, 27(6), 639-661. doi:10.1097/jcp.0b013e31815ac4e5
Cannavo, S., Venturino, M., Curto, L., De Menis, E., D'Arrigo, C., Tita, P., . . . Trimarchi, F. (2003). Clinical presentation and outcome of pituitary adenomas in teenagers. Clin Endocrinol (Oxf), 58(4), 519-527. doi:10.1046/j.1365-2265.2003.01748.x
Casanueva, F. F., Molitch, M. E., Schlechte, J. A., Abs, R., Bonert, V., Bronstein, M. D., . . . Giustina, A. (2006). Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf), 65(2), 265-273. doi:10.1111/j.1365-2265.2006.02562.x
Correll, C. U., & Carlson, H. E. (2006). Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry, 45(7), 771-791. doi:10.1097/01.chi.0000220851.94392.30
ehealthme.com. Will you have Galactocele with Risperdal? Retrieved from https://www.ehealthme.com/ds/risperdal/galactocele/
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000). Prolactin: structure, function, and regulation of secretion. Physiol Rev, 80(4), 1523-1631. doi:10.1152/physrev.2000.80.4.1523
Germann, D., Kurylo, N., & Han, F. (2012). Risperidone. Profiles Drug Subst Excip Relat Methodol, 37, 313-361. doi:10.1016/B978-0-12-397220-0.00008-8
Haddad, P. M., & Wieck, A. (2004). Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs, 64(20), 2291-2314. doi:10.2165/00003495-200464200-00003
Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012). Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options. Eur Child Adolesc Psychiatry, 21(9), 477-492. doi:10.1007/s00787-012-0286-5
Holt, R. I., & Peveler, R. C. (2011). Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management. Clin Endocrinol (Oxf), 74(2), 141-147. doi:10.1111/j.1365-2265.2010.03814.x
Inder, W. J., & Castle, D. (2011). Antipsychotic-induced hyperprolactinaemia. Aust N Z J Psychiatry, 45(10), 830-837. doi:10.3109/00048674.2011.589044
Kearns, A. E., Goff, D. C., Hayden, D. L., & Daniels, G. H. (2000). Risperidone-associated hyperprolactinemia. Endocr Pract, 6(6), 425-429. doi:10.4158/EP.6.6.425
Kim, M. J., Kim, E. K., Park, S. Y., Jung, H. K., Oh, K. K., & Seok, J. Y. (2006). Galactoceles mimicking suspicious solid masses on sonography. J Ultrasound Med, 25(2), 145-151. doi:10.7863/jum.2006.25.2.145
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., . . . Research Units on Pediatric Psychopharmacology Autism, N. (2002). Risperidone in children with autism and serious behavioral problems. N Engl J Med, 347(5), 314-321. doi:10.1056/NEJMoa013171
McNeil, S. E., Gibbons, J. R., & Cogburn, M. (2020). Risperidone. In StatPearls. Treasure Island (FL).
Montgomery, J., Winterbottom, E., Jessani, M., Kohegyi, E., Fulmer, J., Seamonds, B., & Josiassen, R. C. (2004). Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment. J Clin Psychiatry, 65(11), 1491-1498. doi:10.4088/jcp.v65n1108
Naidoo, U., Goff, D. C., & Klibanski, A. (2003). Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology, 28 Suppl 2, 97-108. doi:10.1016/s0306-4530(02)00129-4
Obrist, P., Schwabegger, A., Brunhuber, T., Schafer, G., & Kreczy, A. (2003). Galactocele in a young male patient. Plast Reconstr Surg, 112(1), 186-188. doi:10.1097/01.PRS.0000066172.74112.85
Perez-Boscollo, A. C., Dutra, R. A., Borges, L. G., Stafuzza Goncalves, E. M., Etchebehere, R. M., Rocha, R. L., . . . Ribeiro, T. C. (2009). Galactocele: an unusual cause of breast enlargement in children. J Pediatr Surg, 44(7), e1-3. doi:10.1016/j.jpedsurg.2009.04.009
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014). The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. CNS Drugs, 28(5), 421-453. doi:10.1007/s40263-014-0157-3
Poiana, C., Chirita, C., Carsote, M., Hortopan, D., & Goldstein, A. (2009). Galactocele and prolactinoma--a pathogenic association? Maturitas, 62(1), 98-102. doi:10.1016/j.maturitas.2008.10.015
Serretti, A., & Chiesa, A. (2011). A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol, 26(3), 130-140. doi:10.1097/YIC.0b013e328341e434
Sievertsen, G. D., Lim, V. S., Nakawatase, C., & Frohman, L. A. (1980). Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. J Clin Endocrinol Metab, 50(5), 846-852. doi:10.1210/jcem-50-5-846
Vlahovic, A., Djuricic, S., Todorovic, S., Djukic, M., Milanovic, D., & Vujanic, G. M. (2012). Galactocele in male infants: report of two cases and review of the literature. Eur J Pediatr Surg, 22(3), 246-250. doi:10.1055/s-0032-1308694
Vlahovic, A., Djuricic, S. M., & Todorovic, S. (2015). Unilateral galactocele in a male infant. Vojnosanit Pregl, 72(2), 188-191. doi:10.2298/vsp1502188v